These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 22422501

  • 1. Levels of plasma-soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) are correlated with disease activity in rheumatoid arthritis.
    Choi ST, Kang EJ, Ha YJ, Song JS.
    J Rheumatol; 2012 May; 39(5):933-8. PubMed ID: 22422501
    [Abstract] [Full Text] [Related]

  • 2. Soluble triggering receptor expressed on myeloid cell-1 (sTREM-1): a new mediator involved in early ankylosing spondylitis.
    Chen CH, Liao HT, Chen HA, Liang TH, Wang CT, Chou CT.
    J Rheumatol; 2008 Sep; 35(9):1846-8. PubMed ID: 18634145
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Circulating TNFRI and TNFRII levels correlated with the disease activity score (DAS28) in rheumatoid arthritis.
    Valle Y, Ledezma-Lozano IY, Torres-Carrillo N, Padilla-Gutiérrez JR, Navarro-Hernández RE, Vázquez-Del Mercado M, Palafox-Sánchez CA, Armendáriz-Borunda J, Muñoz-Valle JF.
    Scand J Rheumatol; 2009 Sep; 38(5):332-5. PubMed ID: 19579138
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Expression of a soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) correlates with clinical disease activity in intestinal Behcet's disease.
    Jung YS, Kim SW, Yoon JY, Lee JH, Jeon SM, Hong SP, Kim TI, Kim WH, Cheon JH.
    Inflamm Bowel Dis; 2011 Oct; 17(10):2130-7. PubMed ID: 21910175
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.
    Rioja I, Hughes FJ, Sharp CH, Warnock LC, Montgomery DS, Akil M, Wilson AG, Binks MH, Dickson MC.
    Arthritis Rheum; 2008 Aug; 58(8):2257-67. PubMed ID: 18668547
    [Abstract] [Full Text] [Related]

  • 11. Elevated serum concentrations of triggering receptor expressed on myeloid cells-1 in diffuse cutaneous systemic sclerosis: association with severity of pulmonary fibrosis.
    Tomita H, Ogawa F, Hara T, Yanaba K, Iwata Y, Muroi E, Yoshizaki A, Komura K, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Sato S.
    J Rheumatol; 2010 Apr; 37(4):787-91. PubMed ID: 20156945
    [Abstract] [Full Text] [Related]

  • 12. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G, Lambiri I, Nagel R, Keysser C, Keysser M, Gromnica-Ihle E, Franz J, Burmester GR, Jung K.
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [Abstract] [Full Text] [Related]

  • 13. Correlation of serum-soluble triggering receptor expressed on myeloid cells-1 with clinical disease activity in inflammatory bowel disease.
    Park JJ, Cheon JH, Kim BY, Kim DH, Kim ES, Kim TI, Lee KR, Kim WH.
    Dig Dis Sci; 2009 Jul; 54(7):1525-31. PubMed ID: 18975078
    [Abstract] [Full Text] [Related]

  • 14. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
    Mahmoud RK, El-Ansary AK, El-Eishi HH, Kamal HM, El-Saeed NH.
    Ital J Biochem; 2005 Jul; 54(3-4):248-57. PubMed ID: 16688934
    [Abstract] [Full Text] [Related]

  • 15. Associations between acute phase reactant levels and disease activity score (DAS28) in patients with rheumatoid arthritis.
    Yildirim K, Karatay S, Melikoglu MA, Gureser G, Ugur M, Senel K.
    Ann Clin Lab Sci; 2004 Jul; 34(4):423-6. PubMed ID: 15648784
    [Abstract] [Full Text] [Related]

  • 16. Soluble triggering receptor expressed on myeloid cells 1 and the diagnosis of sepsis.
    Barati M, Bashar FR, Shahrami R, Zadeh MH, Taher MT, Nojomi M.
    J Crit Care; 2010 Jun; 25(2):362.e1-6. PubMed ID: 19914031
    [Abstract] [Full Text] [Related]

  • 17. Thrombin-cleaved osteopontin is increased in urine of patients with rheumatoid arthritis.
    Shio K, Kobayashi H, Asano T, Saito R, Iwadate H, Watanabe H, Sakuma H, Segawa T, Maeda M, Ohira H.
    J Rheumatol; 2010 Apr; 37(4):704-10. PubMed ID: 20156944
    [Abstract] [Full Text] [Related]

  • 18. sTREM-1 in patients with chronic kidney disease on hemodialysis.
    Essa ES, Elzorkany KM.
    APMIS; 2015 Nov; 123(11):969-74. PubMed ID: 26495896
    [Abstract] [Full Text] [Related]

  • 19. IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis.
    Kim WU, Yoo WH, Park W, Kang YM, Kim SI, Park JH, Lee SS, Joo YS, Min JK, Hong YS, Lee SH, Park SH, Cho CS, Kim HY.
    J Rheumatol; 2000 Mar; 27(3):575-81. PubMed ID: 10743792
    [Abstract] [Full Text] [Related]

  • 20. Soluble triggering receptor expressed on myeloid cells-1 is a biomarker of anti-CCP-positive, early rheumatoid arthritis.
    Molad Y, Ofer-Shiber S, Pokroy-Shapira E, Oren S, Shay-Aharoni H, Babai I.
    Eur J Clin Invest; 2015 Jun; 45(6):557-64. PubMed ID: 25832796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.